Johnson & Johnson said late Thursday it will lower prices for certain prescription drugs and match the rates in other ...

NEW YORK, Jan 9 (Reuters) - Healthcare dealmakers are heading to San Francisco this weekend betting ‌on a ​new wave of ...

At the JPMorgan Healthcare Conference, drugmakers are expected to roll out key business and drug pipeline updates and splashy ...

The Schwab U.S. Dividend Equity ETF remains an excellent choice for income-seeking investors, even net of its recent ...

Next week, drugmakers will arrive at the JPMorgan Healthcare Conference in San Francisco feeling far more confident than in ...

In early January 2026, UBS upgraded Bristol-Myers Squibb after highlighting its broad drug pipeline, new clinical trial initiations, and progress on products aimed at easing upcoming patent ...

Bristol Myers Squibb (BMS) has agreed as part of a deal with the US government to provide Eliquis (apixaban) free of charge ...

Meanwhile, another $70 million to $80 million of IPO proceeds is expected to fund the launch a phase 1b study of its second ...

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on ...

After signing a drug pricing deal with the White House, J&J will now offer some of its branded medicines at discounted rates ...

Bayer's Monsanto moved to dismiss 89 of the 121 Roundup lawsuits in New Jersey state courts, citing jursidictional problems.